Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • March 2018
  • Teaching Note
  • HBS Case Collection

Adaptive Platform Trials: The Clinical Trial of the Future?

By: Ariel D. Stern and Sarah Mehta
  • Format:Print
  • | Language:English
  • | Pages:14
ShareBar

Abstract

This teaching note provides guidance and recommendations for teaching HBS Case No. 618-025, entitled “Adaptive Platform Trials: The Clinical Trial of the Future?”

Keywords

Clinical Trials; Drug Trials; Drug Testing; Cancer Trials; Glioblastoma; Platform Trials; Adaptive Trials; Adaptive Platform Trials; Health Testing and Trials; Health Care and Treatment; Business Strategy; Health Industry; United States

Citation

Stern, Ariel D., and Sarah Mehta. "Adaptive Platform Trials: The Clinical Trial of the Future?" Harvard Business School Teaching Note 618-048, March 2018.
  • Purchase

About The Author

Ariel D. Stern

Technology and Operations Management
→More Publications

More from the Authors

    • Harvard Business Manager

    Ein Booster für die Pharmabranche: Gerade erst hat die mRNATechnologie geholfen, Impfstoffe gegen Covid-19 zu entwickeln. Nun könnte sie wie Apples iOS die Grundlage für neue Innovationsplattformen bieten.

    By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
    • April 18, 2022
    • Harvard Business Review (website)

    Will mRNA Technology Companies Spawn Innovation Ecosystems?

    By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
    • April 2022
    • NEJM Catalyst Innovations in Care Delivery

    AI Insurance: How Liability Insurance Can Drive the Responsible Adoption of Artificial Intelligence in Health Care

    By: Ariel Dora Stern, Avi Goldfarb and Timo Minssen
More from the Authors
  • Ein Booster für die Pharmabranche: Gerade erst hat die mRNATechnologie geholfen, Impfstoffe gegen Covid-19 zu entwickeln. Nun könnte sie wie Apples iOS die Grundlage für neue Innovationsplattformen bieten. By: Ariel Dora Stern, Timo Minssen, W. Nicholson Price, II and Christoph Grimpe
  • Will mRNA Technology Companies Spawn Innovation Ecosystems? By: Christoph Grimpe, Timo Minssen, W. Nicholson Price, II and Ariel Dora Stern
  • AI Insurance: How Liability Insurance Can Drive the Responsible Adoption of Artificial Intelligence in Health Care By: Ariel Dora Stern, Avi Goldfarb and Timo Minssen
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College